Where did Andrew Funderburk go to school?

Andrew Funderburk studied at Harvard Business School (MBA); Princeton University (AB, Economics).

Andrew Funderburk

Chief Investor Relations and Strategy Officer at Monte Rosa Therapeutics

Cambridge, Massachusetts, United States

Find your path to Andrew

582 people in our graph share verified history with Andrew — schools, employers, funds. One of them is your warm intro.

Tom HulmeunlockedAndrew: together at Harvard Business School (2005)

×8Andrew: together at Harvard Business School

×3Andrew: together at Princeton University

Chief Investor Relations and Strategy Officer at Monte Rosa Therapeutics

Intro paths

→

In turn, Andrew can intro founders to Monte Rosa Therapeutics's investors below.

Monte Rosa Therapeutics's investors · 8

Aisling CapitalNew York Amzak HealthNew York Avoro Capital AdvisorsNew York Dimension CapitalSan Francisco · $1M – $10M checks GV (Google Ventures)Mountain View · $250K – $50M checks · since 2020 HBM PartnersZug · $5M – $50M checks New Enterprise Associates (NEA)Menlo Park · $200K – $40M checks · since 2020 Versant VenturesSan Francisco · $250K – $5M checks · since 2020

Experience

Monte Rosa TherapeuticsChief Investor Relations and Strategy Officercurrent2026 — presentBoston, MA
Monte Rosa TherapeuticsSVP Investor Relations and Strategic Finance2024 — 2026Boston, MA
Kendall Investor Relations, LLCManaging Director2020 — 2024Cambridge, Massachusetts, United States
Kendall Investor Relations, LLCVice President2020Cambridge, Massachusetts, United States
Health AdvancesPartner, Managing Director (2019-2020)2014 — 2020Newton, Massachusetts, United States
Health AdvancesVice President2009 — 2013
Health AdvancesManager2007 — 2009
Health AdvancesAssociate2005 — 2007
GenentechMBA intern2004
Harvard Business SchoolResearch Associate2001 — 2003
MonitorConsultant1999 — 2001

Skills & more

Business StrategyStrategic PlanningFinancial ModelingManagement ConsultingDue DiligenceMarket ResearchMarketing StrategyCompetitive AnalysisMergersBusiness DevelopmentProduct DevelopmentStrategy

+6 more

Financial AnalysisMergers & AcquisitionsManagementMarket AnalysisBiotechnologyOncology

From Andrew's professional profile.

Frequently asked questions

Who is Andrew Funderburk?: Chief Investor Relations and Strategy Officer at Monte Rosa Therapeutics
Where does Andrew Funderburk work?: Andrew Funderburk is Chief Investor Relations and Strategy Officer at Monte Rosa Therapeutics.
Where did Andrew Funderburk go to school?: Andrew Funderburk studied at Harvard Business School (MBA); Princeton University (AB, Economics).

Same school

Also attended Harvard Business School2,000

Brad GerstnerFounder & CEO of Altimeter Capital Aileen LeeFounder & Managing Partner of Cowboy Ventures Jim BreyerFounder & CEO of Breyer Capital Tim DraperFounder of Draper Associates Mike Maples JrCo-founding Partner at Floodgate Mamoon HamidPartner at Kleiner Perkins

+ 1,994 more

Also attended Princeton University997

Fabrice GrindaCo-founder & Managing Partner at FJ Labs Ryan SheaCo-founder of Blockstack (Stacks)Dario AmodeiCo-founder & CEO of Anthropic Fei-Fei LiCo-founder & CEO of World Labs; Sequoia Professor of Computer Science at Stanford Cat WuInvestor at Index Ventures AndrewAdvisor at Clear Ventures

+ 991 more

Shared employers

Also worked at Monte Rosa Therapeutics7

Alex MaywegManaging Director at Versant Ventures Sunny ReddyPrincipal at Aisling Capital Michael RapePartner at The Column Group Markus WarmuthVenture Partner at Versant Ventures Sharon TownsonPh.D., Chief Scientific Officer at Monte Rosa Therapeutics John CastlePh.D., Chief Data and Information Officer at Monte Rosa Therapeutics

+ 1 more

Also worked at Health Advances13

David NarrowVenture Advisor at Cultivation Capital Jordan SilvaCampus Lead at The MBA Fund Russ RapaportAssociate at 1315 Capital David SietPrincipal at Amzak Health William CliffordPartner at Oberland Capital Samantha TruexInvestor at Avalo Therapeutics

+ 7 more

Also worked at Genentech245

David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Marco PrunottoInvestor at Medicxi Logan HilleLife Sciences Analyst at CincyTech Josephine ChenInvestor at Sequoia Capital Abbie CelnikerInvestor at Third Rock Ventures

+ 239 more

Also worked at Harvard Business School326

Noubar AfeyanInvestor at Flagship Pioneering Gizem CakilInvestor at OpenView Venture Partners Eric PaleyEntrepreneur and Seed Investor in Cambridge, MA Lauren LeeInvestor at FJ Labs Mark LurieVenture Partner at FJ Labs Alice BrooksInvestor at Khosla Ventures

+ 320 more